The COVID-19 pandemic has spurred genomic surveillance of viruses on an unprecedented scale, as scientists around the world use genome sequencing to track the spread of new variants of the SARS-CoV-2...
A new study from Boston Children’s Hospital and the Massachusetts Department of Health compared one of the latest rapid antigen tests for COVID-19—the Abbott BinaxNOW—with a highly accurate...
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19.
Rebecca DuBois, associate professor of biomolecular...
The number of patients starting anticancer therapies dropped by more than 30 per cent in April, the month following the UK’s first COVID-19 lockdown, but went above pre-pandemic levels within three...
TUESDAY, Sept. 29, 2020 — The U.S. government will start distributing millions of rapid COVID-19 tests to states this week with the goal of reopening schools.
About 6.5 million tests will be shipped...
The Trump administration has announced a plan to distribute millions of rapid COVID-19 tests to states, with a focus on using the tests to reopen schools.
On Monday (Sept. 28), President Donald Trump said...
The CA125 antigen, a plasma membrane glycoprotein found in the tissues of the female reproductive tract, is commonly used for the detection of ovarian cancer but works poorly on its own in identifying...
With an increase in HIV and HCV infections as a consequence of the ongoing opioid epidemic, Boston Medical Center researchers found that only a small number of those who test positive for those infections...
It may seem like a lifetime ago, but it was only in late January 2020 that Singapore confirmed its first case of the then-novel coronavirus causing COVID-19. Amid the frenzied atmosphere of the Chinese...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok